1. Atsushi Nara, Hiroki Ueda, Keiichi Akahoshi, Akira Ito, Shotaro Gan, Hironari Yamashita, Koichiro Morimoto, Daisuke Asano, Shuichi Watanabe, Yoshiya Ishikawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Preoperative sarcopenia assessment predicts loss of independence after Pancreaticoduodenectomy (PD) in pancreatic cancer patients. The 3rd International Congress of the Asian Oncology Society 2023.10.20 Yokohama

  2. Akira Ito, Keiichi Akahoshi, Shotaro Gan, Atsushi Nara, Koichiro Morimoto, Hironari Yamashita, Daisuke Asano, Shuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Prognostic Impact of Reticular Pattern around Superior Mesenteric Artery in CT Images of Pancreatic Cancer. The 3rd International Congress of the Asian Oncology Society 2023.10.20 Yokohama

  3. Shotaro Gan, Daisuke Asano, Akira Ito, Atsushi Nara, Koichiro Morimoto, Hironari Yamashita, Shuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Determining the Indication of Surgery for High grade pNENs. The 3rd International Congress of the Asian Oncology Society 2023.10.20 Yokohama

  4. Hironari Yamashita, Hiroaki Ono, Kotaro Takizawa, Shuichi Watanabe, Kosuke Ogawa, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Atsushi Kudo, Yoshimitsu Akiyama, Shinji Tanaka, Minoru Tanabe. PCNA-I1 is identified as a novel therapeutic agent in pancreatic cancer. The 82nd Annual Meeting of the Japanese Cancer Association 2023.09.23 Yokohama

  5. Hiroaki Ono, Keiichi Akahoshi, Shinji Tanaka, Minoru Tanabe. RRM1 is mediated by H3 acetylation through GEM resistance and contributes to invasiveness and ECM remodeling in PDAC. The 82nd Annual Meeting of the Japanese Cancer Association 2023.09.23 Yokohama

  6. Koya Yasukawa, Shu Shimada, Yoshimitsu Akiyama, Shinji Tanaka. Elucidation of immunotherapy resistance in hepatocellular carcinoma: Novel treatment based on lactate metabolism. The 82nd Annual Meeting of the Japanese Cancer Association 2023.09.22 Yokohama

  7. Yoshimitsu Akiyama, Shu Shimada, Shinji Tanaka. Overexpression of PADI2 and histone citrullination change in gastric cancer. The 82nd Annual Meting of the Japanese Cancer Association 2023.09.21 Yokohama

  8. Hironari Yamashita, Hiroaki Ono, Daisuke Asano, Shuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Proliferating cell nuclear antigen (PCNA) plays important role in malignancy of pancreatic cancer and might be the target protein of novel therapeutic drug. The 35th Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2023.07.01 Tokyo

  9. Shotaro Gan, Daisuke Asano, Masaru Takeuchi, Masahiro Yamane, Akira Ito, Atsushi Nara, Koichiro Morimoto, Hironari Yamashita, Kohei Yagi, Shuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Hiroaki Ono, Keiichi Akahoshi, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. A case of unresectable pancreatic ductal adenocarcinoma (UR-PDAC) in an elderly patient who underwent radical resection after preoperative chemotherapy and survived without recurrence for 1 year. The 35th Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2023.07.01 Tokyo

  10. Masahiro Yamane, Yoshiya Ishikawa, Masaru Takeuchi, Shotaro Gan, Kohei Yagi, Daisuke Asano, Shuichi Watanabe, Hiroki Ueda, Keiichi Akahoshi, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Middle-segment Preserving Pancreatectomy versus Total pancreatectomy: a comparative study of surgical and functional outcomes. The 35th Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2023.07.01 Tokyo

  11. Hiroaki Ono, Daisuke Asano, Shuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Emerging Multidisciplinary Therapies Including PRRT Therapy in Pancreatic Neuroendocrine Neoplasms. The 35th Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2023.07.01 Tokyo

  12. Hiroki Ueda, Atsushi Nara, Masaru Takeuchi, Masahiro Yamane, Akira Ito, Koichiro Morimoto, Hironari Yamashita, Kohei Yagi, Daisuke Asano, Yoshiya Ishiakwa, Shuichi Watanabe, Keiichi Akahoshi, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Age and Sarcopenia Are Risk Factors for ADL Decline After Pancreaticoduodenectomy; Our approach to maintain ADLs before and after surgery. The 35th Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2023.07.01 Tokyo

  13. Koichiro Morimoto, Hiroki Ueda, Daisuke Asano, Shuichi Watanabe, Yoshiya Ishikawa, Keiichi Akahoshi, Shinji Tanaka, Minoru Tanabe. Characteristics of refractory postoperative cholangitis after hepatectomy with hepaticojejunostomy: Anastomotic stenosis is not the only cause. The 35th Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2023.07.01 Tokyo

  14. Yoshiya Ishikawa, Yuzuki Sugiyama, Satoru Muro, Masahiro Yamane, Masaru Takeuchi, Daisuke Asano, Shuichi Watanabe, Hiroki Ueda, Keiichi Akahoshi, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Keiichi Akita, Minoru Tanabe. Novel landmarks for the left posterior approach to the SMA based on the anatomical research. The 35th Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2023.07.01 Tokyo

  15. Shuichi Watanabe, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Investigation of recurrence format of single recurrent lesions using genomic analysis. The 35th Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2023.07.01 Tokyo

  16. Daisuke Asano, Keiichi Akahoshi, Yoshiya Ishikawa, Shuichi Watanabe, Hiroki Ueda, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. How to achieve the negative surgical margin for ICC suspicious of invasion to hilum: with the video of laparoscopic left hepatectomy by hilar dissection approach. The 35th Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2023.07.01 Tokyo

  17. Akira Ito, Keiichi Akahoshi, Masaru Takeuchi, Masahiro Yamane, Shotaro Gan, Atsushi Nara, Koichiro Morimoto, Munetaka Kimura, Hironari Yamashita, Kohei Yagi, Daisuke Asano, Yoshiya Ishikawa, Shuichi Watanabe, Hiroki Ueda, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Hepatectomy After Pancreatoduodenectomy Has a High Risk of Postoperative Complications. The 35th Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2023.06.30 Tokyo

  18. Atsushi Nara, Keiichi Akahoshi, Akira Ito, Shotaro Gan, Daisuke Asano, Shuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Pancreatic duct stent AMY after pancreaticoduodenectomy is a predictor of pancreatic fistula. The 35th Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2023.06.30 Tokyo

  19. Shinji Tanaka. Educational Session：New currents in the field of HBP surgery. The 35th Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2023.06.30 Tokyo

  20. Shu Tsukihara, Yoshimitsu Akiyama, Shu Shimada, Megumi Hatano, Yusuke Kinugasa, Ken Eto, Shinji Tanaka. Histone H3 lysin 9 methyltransferase SETDB1 promotes gastric carcinogenesis by multiple signaling pathways. Digestive Disease Week 2023 2023.05.10 Chicago

  21. A.Nara, K.Akahoshi, H.Ueda, D.Asano, S.Watanabe, Y.Ishikawa, H.Ono, A.Kudo, S.Tanaka, M.Tanabe. Usefulness of the NRSS in Determining the Timing of TAE for Ruptured Hepatocellular Carcinoma. 18th Annual Academic Surgical Congress 2023.02.08 Houston

  1. Keiichi Akahoshi, Yoshiya Ishikawa, Daisuke Asano, Hiroki Ueda, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Safety methods to perform laparoscopic liver resection for liber cirrhosis. ACRLS 2022 2022.12.09 Nagoya

  2. Shinji Tanaka. Surgical oncology to elucidate molecular and immunological mechanisms for clinical application in hepato-biliary-pancreatic cancer (lecture). UCh-TMDU Joint Symposium 2022.11.08 Chile（on-line）

  3. Atsushi Nara, Keiichi Akahoshi, Hiroki Ueda, Koichiro Morimoto, Masaru Takeuchi, Masahiro Yamane, Akira Ito, Shotaro Gan, Munetaka Kimura, Hironari Yamashita, Kohei Yagi, Daisuke Asano, Shuichi Watanabe, Yoshiya Isikawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Usefulness of the Novel Rupture Severity Score (NRSS) in Determining the Timing of Transarterial Embolization (TAE) for Ruptured Hepatocellular Carcinoma. IASGO-CME 2022.10.26 Fukuoka

  4. 田中 真二. がんの進展・浸潤に関与する新たな分子生物学的マーカーの開発　外科臨床に基づく難治性がんの分子免疫機序と治療戦略. 日本癌治療学会学術集会抄録集 2022.10.01

  5. 谷合 智彦, 島田 周, 秋山 好光, 樺嶋 彩乃, 下川 雅弘, 八木 宏平, 赤星 径一, 春木 孝一郎, 田邉 稔, 池上 徹, 田中 真二. 肝細胞癌におけるVETC/MTMの臨床的意義とマウスモデルを用いた免疫療法奏功の検討. 日本癌治療学会学術集会抄録集 2022.10.01

  6. Shinji Tanaka. Workshop 9：Molecular mechanisms of liver cancer (including HCC, CCC, metastatic liver cancer) , Molecular and immunological mechanisms of liver cancer; preclinical studies for clinical application (invited lecture). APASL Oncology 2022 2022.09.01 Takamatsu (on-line)

  7. 島田 周, 秋山 好光, 田中 真二. CRISPR/Cas9システムを用いたエクソンスキッピングによるβ-cateninシグナルの内在性活性化が肝がん細胞の免疫回避に寄与する(Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in HCC). 日本癌学会総会記事 2022.09.01

  8. Ono Hiroaki, Murase Yoshiki, Asano Daisuke, Watanabe Syuuichi, Ishikawa Yoshiya, Ueda Hiroki, Akahoshi Keiichi, Kudo Atsushi, Tanaka Shinji, Tanabe Minoru. Basic & translational researches on PanNEN: bench to bedside　Evaluation of the efficacy of Ispinesib, a novel Eg 5 inhibitor, for the treatment of high grade Pan-NENs(タイトル和訳中). 膵臓 2022.09.01

  9. 秋山 好光, 島田 周, 田邉 稔, 田中 真二. 膵癌におけるヒストンH3K4メチル化酵素SETD1A発現の臨床的及び生物学的意義(Prognostic and biological significance of overexpression of SEID1A histone H3K4 methyltransferase in pancreatic cancer). 日本癌学会総会記事 2022.09.01

  10. 島田 周, 秋山 好光, 田中 真二. CRISPR/Cas9システムを用いたエクソンスキッピングによるβ-cateninシグナルの内在性活性化が肝がん細胞の免疫回避に寄与する(Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in HCC). 日本癌学会総会記事 2022.09.01

  11. Hiroaki Ono, Yoshiki Murase, Daisuke Asano, Syuuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Evaluation of the efficacy of Ispinesib, a novel Eg5 inhibitor, for the treatment of high grade Pan-NENs. Joint Congress of the 26th Meeting of IAP and the 53rd Annual Meeting of JPS 2022.07.08 Kyoto

  12. Daisuke Asano, Yoshiya Ishikawa, Shuichi Watanabe, Hiroki Ueda, Keiichi Akahoshi, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. The novel techniques of distal pancreatectomy using articulation forceps -introducing the desterity of a robotic system to a palaroscopic surgery. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.11 Ehime

  13. Akira Ito, Daisuke Asano, Shotaro Gan, Atsushi Nara, Koichiro Morimoto, Munetaka Kimura, Hironari Yamashita, Kohei Yagi, Takeshi Ishii, Yoshiya Ishikawa, Shuichi Watanabe, Hiroki Ueda, Keiichi Akahoshi, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Strategy of pancreatic ductal adenocarcinoma treatment. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.11 Ehime

  14. Daisuke Asano, Atushi Kudo, Yoshiya Ishikawa, Shuichi Watanabe, Hiroki Ueda, Keiichi Akahoshi, Hiroaki Ono, Shinji Tanaka, Minoru Tanabe. Reappraisal of surgical treatment for liver metastases of neuroendocrine neoplasms. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.11 Ehime

  15. Yoshiya Ishikawa, Daisuke Asano, Shuichi Watanabe, Hiroki Ueda, Keiichi Akahoshi, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Safe approach to dissect hepatoduodenal ligament during laparoscopic pancreaticoduodenectomy. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.11 Ehime

  16. Shotaro Gan, Hiroki Ueda, Atsushi Nara, Akira Ito, Koichiro Morimoto, Hironari Yamashita, Munetaka Kimura, Kohei Yagi, Takeshi Ishii, Daisuke Asano, Shuichi Watanabe, Yoshiya Ishikawa, Keiichi Akahoshi, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Discussion on the treatment of liver cysts at our hospital. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.11 Ehime

  17. Akira Ito, Daisuke Asano, Shotaro Gan, Atsushi Nara, Koichiro Morimoto, Munetaka Kimura, Hironari Yamashita, Kohei Yagi, Takeshi Ishii, Yoshiya Ishikawa, Shuichi watanabe, Hiroki Ueda, Keiichi Akahoshi, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe . Strategy of pancreatic ductal adenocarcinoma treatment. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.11 Ehime

  18. Aya Maekawa, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Hormonaltumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.11 Ehime

  19. Shinji Tanaka. Workshop 2: Innovative research of biomarkers for HBP cancers, Biomarker research and clinical application for treatment of hepato-biliary-pancreatic cancer　(invited lecture). The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.10 Matsuyama (on-line)

  20. Hiroki Ueda, Daisuke Asano, Shuichi Watanabe, Yoshiya Ishikawa, Keiichi Akahoshi, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Clinical features of malignant insulinoma from single center experience. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.10 Ehime

  21. Hironari Yamashita, Keiichi Akahoshi, Akira Ito, Shoutaro Gan, Atsushi Nara, Munetaka Kimura, Koichiro Morimoto, Kohei Yagi, Takeshi Ishi, Daisuke Asano, Yoshiya Ishikawa, Shuichi Watanabe, Hiroki Ueda, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Clinical outcome of pT1 pancreatic ductal adenocarcinoma-what is the risk factor of poor prognosis?. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.10 Ehime

  22. Atsushi Nara, Hiroki Ueda, Yukue Shimizu, Daisuke Asano, Yoshiya Ishikawa, Shuichi Watanabe, Keiichi Akahoshi, Hiroaki Ono, Shinji Tanaka, Minoru Tanabe. Evaluation of sarcopenia using preoperative InBody and short-term results after pancreaticoduodenectomy. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.10 Ehime

  23. Keiichi Akahoshi, Akira Ito, Atsushi Nara, Shotaro Gan, Takeshi Ishii, Kohei Yagi, Koichiro Morimoto, Hironari Yamashita, Munetaka Kimura, Daisuke Asano, Shuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Transpapillary or transmural drainage for postoperative pancreatic fistula after distal pancreatectomy. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.10 Ehime

  24. Hiroaki Ono, Daisuke Asano, Shuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Validation of surgical resection for pancreatic neuroendocrine neoplasms with simulataneous liver metastases. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.10 Ehime

  25. Kohei Yagi, Hiroaki Ono, Atsushi Kudo, Akira Ito, Atsushi Nara, Syotaro Gan, Munetaka Kimura, Hironari Yamashita, Takeshi Ishii, Daisuke Aasano, Syuichi Watanabe, Hiroki Ueda, Yoshiya Ishikawa, Keiichi Akahoshi, Shinji Tanaka, Minoru Tanabe. Significance of MGMT expression for streptozocin treatment of pancreatic neuroendocrine neoplasms. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.10 Ehime

  26. Takeshi Ishii, Keiichi Akahoshi, Koichirou Morimoto, Hironari Yamashita, Kouhei Yagi, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. A single-center retrospective study of 17 cases of pancreatic metastasis from renal cell carcinoma. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.10 Ehime

  27. Koichiro Morimoto, Hiroki Ueda, Daisuke Asano, Yoshiya Ishikawa, Syuichi Watanebe, Keiichi Akahoshi, Hiroaki Ono, Atushi Kudo, Shinji Tanaka, Minoru Tanabe. Risk factors of postoperative cholangitis after hepatectomy with hepato-jejunostomy for malignancy-Clumping test predicts late refractory cholangitis. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.10 Ehime

  28. Hiroki Ueda, Daisuke Asano, Shuichi Watanabe, Yoshiya Ishikawa, Keiichi Akahoshi, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Clinical features of malignant insulinoma from single center experience. The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2022.06.10

  29. Nara Atsushi, Ueda Hiroki, Shimizu Yukue, Asano Daisuke, Ishikawa Yoshiya, Watanabe Shuichi, Akahoshi Keiichi, Ono Hiroaki, Tanaka Shinji, Tanabe Minoru. InBodyを用いたサルコペニアの術前評価と膵頭十二指腸切除術後の短期成績(Evaluation of sarcopenia using preoperative InBody and short-term results after pancreaticoduodenectomy). 日本肝胆膵外科学会・学術集会プログラム・抄録集 2022.06.01

  30. Yamashita Hironari, Akahoshi Keiichi, Ito Akira, Gan Shoutaro, Nara Atsushi, Kimura Munetaka, Morimoto Koichiro, Yagi Kouhei, Ishi Takeshi, Asano Daisuke, Ishikawa Yoshiya, Watanabe Shuichi, Ueda Hiroki, Ono Hiroaki, Kudo Atsushi, Tanaka Shinji, Tanabe Minoru. pT1膵管腺癌の臨床転帰　予後不良の危険因子は何か?(Clinical outcome of pT1 pancreatic ductal adenocarcinoma: what is the risk factor of poor prognosis?). 日本肝胆膵外科学会・学術集会プログラム・抄録集 2022.06.01

  31. Asano Daisuke, Ishikawa Yoshiya, Watanabe Shuichi, Ueda Hiroki, Akahoshi Keiichi, Ono Hiroaki, Kudo Atsushi, Tanaka Shinji, Tanabe Minoru. 多自由度鉗子を用いた膵体尾部切除術の新しい手技　腹腔鏡手術にロボットシステムの器用さを導入するために(The novel techniques of distal pancreatectomy using articulating forceps～introducing the dexterity of a robotic system to a laparoscopic surgery). 日本肝胆膵外科学会・学術集会プログラム・抄録集 2022.06.01

  1. Shinji Tanaka. Invited Lecture; Stemness and heterogeneity of liver cancer. JSH International Liver Conference 2021 2021.10.02 Hakata International Exhibition Hall & Conference Center, Fukuoka （on-line）

  2. 小野 宏晃, 赤星 径一, 田中 真二, 田邉 稔. RRM1は膵臓癌細胞の細胞外マトリックスタンパク質を転換し悪性化形質獲得に寄与している. 日本癌学会総会記事 2021.09.01

  3. 田中 真二. 外科腫瘍学に基づいた肝胆膵癌に対する新規分子標的-免疫併用療法の開発. 日本癌学会総会記事 2021.09.01

  4. Hiroyuki Ishida, Hiroki Ueda, Keiichi Akahoshi, Yoshiya Ishikawa, Hironari Yamashita, Koichiro Morimoto, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Early recurrence after curative hepatectomy for colorectal liver metastases. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  5. Yoshiya Ishikawa, Hiroyuki Ishida, Koichiro Morimoto, Hironari Yamashita, Hiroki Ueda, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma using supracolic anterior approach to the superior mesenteric artery. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  6. Takeshi Ishii, Atsushi Kudo, Yoshiki Murase, Aya Maekawa, Toshitaka Sugawara, Yoshiya Ishikawa, Shuichi Watanabe, Hiroki Ueda, Keiichi Akahoshi, Kousuke Ogawa, Hiroaki Ono, Shinji Tanaka, Minoru Tanabe. The management of GEP-NET with MEN type 1 in our department. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  7. Koichiro Morimoto, Keiichi Akahoshi, Hironari Yamashita, Hiroyuki Ishida, Kohei Yagi, Aya Maekawa, Yoshiki Murase, Takeshi Ishii, Toshitaka Sugawara, Yoshiya Ishikawa, Hiroki Ueda, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Granulomatous Langerhans isletitis followed by nivolumab-induced type 1 diabetes mellitus in a distal pancreatectomy: case report. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  8. Hiroki Ueda, Koichiro Morimoto, Hironari Yamashita, Hiroyuki Ishida, Kohei Yagi, Aya Maekawa, Yoshiki Murase, Toshitaka Sugawara, Takeshi Ishii, Yoshiya Ishikawa, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Perioperative outcomes in elderly patients over 75-years-old undergoing distal pancreatectomy. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  9. Hiroaki Ono, Atsushi Kudo, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Kosuke Ogawa, Shinji Tanaka, Minoru Tanabe. Combination of Weekly Streptozocin and Oral S-1 Treatment is effective treatment for unresectable or metastatic pancreatic NET-G1 and NET-G2 patients. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  10. Kohei Yagi, Hiroki Ueda, Koichiro Morimoto, Hironari Yamashita, Yoshiki Murase, Aya Maekawa, Takeshi Ishii, Toshitaka Sugawara, Shuichi Watanabe, Yoshiya Ishikawa, Keiichi Akashoshi, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, SHinji Tanaka, Minoru Tanabe. A review of resected cases of primary duodenal cancer in our hospital. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  11. Hironari Yamashita, Keiichi Akahoshi, Koichirou Morimoto, Hiroyuki Ishida, Kohei Yagi, Aya Maekawa, Yoshiki Murase, Takeshi Ishii, Toshitaka Sugawara, Yoshiya Ishikawa, Hiroki Ueda, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Effect of neoadjuvant chemotherapy on short-term outcome in patients undergoing pancreaticoduodenectomy for borderline resectable pancreatic cancer and resectable pancreatic cancer with elevated serum tumor markers. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  12. Yoshiki Murase, Hiroaki Ono, Risa Yoshioka, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Kosuke Ogawa, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. High Eg5 expression predicts poor prognosis in pancreatic cancer. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  13. Aya Maekawa, Keiichi Akahoshi, Yoshiya Ishikawa, Hiroki Ueda, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Validation of the international consensus guideline 2017 for intraductal papillary mucinous neoplasms. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  14. Keiichi Akahoshi, Yoshiya Ishikawa, Hiroki Ueda, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Conversion surgery after lenvatinib treatment for advanced hepatocellular carcinoma. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  15. Ueda Hiroki, Morimoto Koichiro, Yamashita Hironari, Ishida Hiroyuki, Yagi Kohei, Maekawa Aya, Murase Yoshiki, Sugawara Toshitaka, Ishii Takeshi, Ishikawa Yoshiya, Akahoshi Keiichi, Ogawa Kosuke, Ono Hiroaki, Kudo Atsushi, Tanaka Shinji, Tanabe Minoru. 75歳以上の高齢患者に対する膵体尾部切除術の周術期成績(Perioperative outcomes in elderly patients over 75-years-old undergoing distal pancreatectomy). 日本肝胆膵外科学会・学術集会プログラム・抄録集 2021.06.01

  16. Ishii Takeshi, Kudo Atsushi, Murase Yoshiki, Maekawa Aya, Sugawara Toshitaka, Ishikawa Yoshiya, Watagebe Shuichi, Ueda Hiroki, Akahoshi Keiichi, Ogawa Kousuke, Ono Hiroaki, Tanaka Shinji, Tanabe Minoru. MEN type 1を伴うGEP-NETの管理(The management of GEP-NET with MEN type1 in our department). 日本肝胆膵外科学会・学術集会プログラム・抄録集 2021.06.01

  17. Maekawa Aya, Akahoshi Keiichi, Ishikawa Yoshiya, Ueda Hiroki, Ogawa Kosuke, Ono Hiroaki, Kudo Atsushi, Tanaka Shinji, Tanabe Minoru. IPMN国際診療ガイドライン2017年版の検証(Validation of the international consensus guideline 2017 for intraductal papillary mucinous neoplasms). 日本肝胆膵外科学会・学術集会プログラム・抄録集 2021.06.01

  18. Tomotaka Kato, Yoshiya Ishikawa, Shuichi Watanabe, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Comparison of open and laparoscopic hepatectomy for obese patients with HCC. The 33rd Annual Meeting of the Japan Society for Endoscopic Surgery 2021.03.10 Yokohama

  19. Kohei Yagi, Atsushi Kudo, Aya Maekawa, Yoshiki Murase, Takeshi Ishii, Tomotaka Kato, Masafumi Akasu, Toshitaka Sugawara, Yoshiya Ishikawa, Shuichi Watanabe, Keiichi Akahoshi, Ogawa Kosuke, Hiroaki Ono, Daisuke Ban, Shinji Tanaka, Minoru Tanabe. Evaluation of laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors. The 32nd Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2021.02.23 Web

  20. Keiichi Akahoshi, Kohei Yagi, Yoshiki Murase, Takeshi Ishii, Toshitaka Sugawara, Yoshiya Ishikawa, Shuichi Watanabe, Kosuke Ogawa, Hiroaki Ono, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Non-viral hepatocellular carcinoma and, diabetes and obesity as its risk factorslar carcinoma and, diabetes and obesity as its risk factors. The 32nd Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2021.02.23 Web

  21. Hiroaki Ono, Tomotaka Kato, Aya Maekawa, Kouhei Yagi, Yoshiya Ishikawa, SHuichi Watanabe, Keiichi Akahoshi, Kousuke Ogawa, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Cytoplasmic RRM1 activation in acute phase of gemcitabine treatment is involved in acquired resistance of pancreatic cancer. The 32nd Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2021.02.23 Web

  22. Takeshi Ishii, Keiichi Akahoshi, Kohei Yagi, Aya Maekawa, Yoshiki Murase, Toshitaka Sugawara, Masafumi Akasu, Tomotaka, Kato, Yoshiya Ishikawa, Shuichi Watanabe, Kousuke Ogawa, Hiroaki Ono, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Clinical Analysis of 23 Cases of total pancreatectomy in Tokyo Medical and Dental University. The 32nd Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2021.02.23 Web

  23. Shuichi Watanabe, Shu Shimada, Jo NIshino, Kohei Yagi, Aya Maekawa, Yoshiki Murase, Toshitaka Sugawara, Takeshi Ishii, Tomotaka Kato, Masafumi Akasu, Yoshiya Ishikawa, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Estimation of the type of HCC metastasis based on the multicellular colonization model. The 32nd Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2021.02.23 Web

  24. Keiichi Akahoshi, Yoshiya Ishikawa, Hiroki Ueda, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Liver resection after systemic chemotherapy improved overallsurvival of metastatic neuroendocrine neoplasms. The 32nd Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2021.02.23 Web

  1. 秋山好光, 吉野潤, 島田周, 田邊稔, 田中真二. ARID1A欠失胆管癌における幹細胞遺伝子ALDH1A1の発現亢進とヒストン修飾変化の関与. 第22回日本肝がん分子標的治療研究会 2020.11.14 金沢

  2. 藤田 征志, 山口 類, 有廣 光司, 島田 周, 宮野 悟, 山上 裕機, 茶山 一彰, 垣見 和宏, 田中 真二, 井元 清哉, 中川 英刀. がん免疫ゲノム解析　肝臓がんの免疫ゲノム解析. 日本癌学会総会記事 2020.10.01

  3. 秋山 好光, 島田 周, 田邉 稔, 田中 真二. 胆管癌におけるARID1A欠失はヒストンアセチル化を介して幹細胞遺伝子ALDH1A1の発現亢進に働く. 日本癌学会総会記事 2020.10.01

  4. 島田 周, 秋山 好光, 田邉 稔, 田中 真二. KDM6A発現低下を特徴とする膵がん予後不良サブタイプにはHDAC阻害剤が著効する. 日本癌学会総会記事 2020.10.01

  1. Tanaka Shinji, Watanabe Shuichi, Tanabe Minoru. バイオマーカー、遺伝子解析の消化器がん診断・治療への応用　サブタイプ特異的オーダーメイド免疫療法のための肝細胞癌の新しい遺伝的および免疫学的分類(Application of biomarker and genetic tests for diagnosis and treatment of gastrointestinal cancers　Novel genetic and immunological classification of hepatocellular carcinoma for the subtype-specific precision immunotherapy). 日本消化器病学会雑誌 2019.11.01

  2. 藤田 征志, 山口 類, 有廣 光司, 島田 周, 宮野 悟, 山上 裕機, 茶山 一彰, 垣見 和宏, 田中 真二, 井元 清哉, 中川 英刀. イムノゲノミクスの進歩と精密医療への応用　肝臓がん免疫抑制機構の免疫ゲノム解析(Advances in immunogenomics and application to precision medicine　Immunogenomic analysis of immune suppression mechanisms in primary liver cancer). 日本癌学会総会記事 2019.09.01

  3. 秋山 好光, 島田 周, 田中 真二. 胃癌におけるヒストンアルギニンメチル化タンパク質PRMT6の高発現は予後と悪性度に関与する(Overexpression of histone arginine methyltransferase PRMT6 contributes to prognosis and malignancy of gastric cancer). 日本癌学会総会記事 2019.09.01

  4. 島田 周, 秋山 好光, 田中 真二. 肝細胞癌の分子生物学的および免疫学的分類(Comprehensive molecular and immunological characterization of hepatocellular carcinoma). 日本癌学会総会記事 2019.09.01

  5. Shuichi Watanabe, Daisuke Ban,Toshiro Ogura,Kosuke Ogawa, Hiroaki Ono,Yusuke Mitsunori,Atsushi Kudo,Shinji Tanaka,Minoru Tanabe. The analysis of the treatment for the metachronous solitary metastasis after curative surgery in pancreatic cancer. The 31st Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2019.06.14 Takamatsu

  6. Toshitaka Sugawara,Daisuke Ban,Takeshi Ishii,Satoshi Matsui,Masahumi Akasu,Tomotaka Kato,Daisuke Asano,Jun Yoshino,Shuichi Watanabe, Toshiro Ogura,Kosuke Ogawa, Hiroaki Ono,Yusuke Mitsunori,Atsushi Kudo,Shinji Tanaka,Minoru Tanabe. Preoperative factors for early recurrence of resected pancreatic ductal adenocarcinoma. The 31st Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2019.06.14 Takamatsu

  7. Takeshi Ishii,Toshiro Ogura,Yoshiki Murase,Toshitaka Sugawara,Masahumi Akasu, Tomotaka Kato,Jun Yoshino,Shuichi Watanabe, Kosuke Ogawa, Hiroaki Ono,Yusuke Mitsunori,Daisuke Ban,Atsushi Kudo,Shinji Tanaka,Minoru Tanabe. Surgery for obese patients with hepatocellular carcinoma. The 31st Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2019.06.13 Takamatsu

  1. 田中 真二. プレシジョンメディシン時代の分子標的治療　プレシジョンメディシン時代の肝癌分子標的治療(Molecular target therapy under precision medicine　Molecular target therapy for liver cancer under precision medicine). 日本癌学会総会記事 2018.09.01

  2. 島田 周, 秋山 好光, 田邉 稔, 田中 真二. メタボリック関連肝癌の腫瘍内星細胞におけるFABP4発現亢進の意義(FABP4 overexpression in intratumoral hepatic stellate cells within hepatocellular carcinoma with metabolic risk factors). 日本癌学会総会記事 2018.09.01

  3. 渡辺 雄一郎, 本田 真也, 小西 昭充, 田邉 稔, 田中 真二, 清水 重臣. オートファジーはCep63を介して中心体数を制御する(Autophagy controls centrosome number by degrading Cep63). 日本癌学会総会記事 2018.09.01

  4. 深町 博史, 西川路 武人, 島田 周, 秋山 好光, 湯浅 保仁, 土屋 輝一郎, 田中 真二. 低分化型胃がんは、形成過程の異なる2つのクラスターに分類できる(Diffuse-type gastric cancers are classified into two clusters, which may be formed via different carcinogenic pathways). 日本癌学会総会記事 2018.09.01

  5. 秋山 好光, 島田 周, 田邉 稔, 田中 真二. 膵内分泌腫瘍においてDAXXはヒストンH3.3/H3K9トリメチル化を介して癌抑制因子として働く(DAXX acts as a tumor suppressor through histone H3.3/H3K9me3 pathway in pancreatic neuroendocrine tumors). 日本癌学会総会記事 2018.09.01

  6. 島田 周, 秋山 好光, 田邉 稔, 田中 真二. メタボリック関連肝癌の腫瘍内星細胞におけるFABP4発現亢進の意義(FABP4 overexpression in intratumoral hepatic stellate cells within hepatocellular carcinoma with metabolic risk factors). 日本癌学会総会記事 2018.09.01

  7. 深町 博史, 西川路 武人, 島田 周, 秋山 好光, 湯浅 保仁, 土屋 輝一郎, 田中 真二. 低分化型胃がんは、形成過程の異なる2つのクラスターに分類できる(Diffuse-type gastric cancers are classified into two clusters, which may be formed via different carcinogenic pathways). 日本癌学会総会記事 2018.09.01

  8. 水野 裕貴, 島田 周, 秋山 好光, 渡邊 秀一, 相田 知海, 小川 康介, 小野 宏晃, 光法 雄介, 伴 大輔, 工藤 篤, 山岡 昇司, 田中 真二, 田邉 稔. 肝細胞癌においてDEPDC5不活化はp62発現上昇を介してロイシン欠乏に対する抵抗性の獲得に寄与する(DEPDC5 deficiency contributes to resistance to leucine starvation via p62 accumulation in hepatocellular carcinoma). 日本癌学会総会記事 2018.09.01

  9. Tomotaka Kato、Daisuke Ban、Keiichi Akahoshi、Toshiro　Ogura、Kosuke Ogawa、Hiroaki　Ono、Yusuke　Mitsunori、Atsushi　Kudo、Shinji　Tanaka、 Minoru Tanabe . Treatment strategies of resectable pancreatic cancer with hazy density around major artery. The 73rd General Meeting of the Japanese Society of Gastroenterological Surgery 2018.07.12 Kagoshima

  10. Shuichi Watanabe、Shu Shimada、Yoshimitsu Akiyama、Kosuke Ogawa、Hiroaki Ono、Yusuke Mitsunori、Daisuke Ban、Atsushi Kudo、Minoru Tanabe、Shinji Tanaka. Precision medicine for the poorest prognosis subtype of pancreatic cancer. The 73rd General Meeting of the Japanese Society of Gastroenterological Surgery 2018.07.12 Kagoshima

  11. Yusuke Mitsunori,Masafumi Akasu,Tomotaka Kato,Jun Yoshino, Shuichi Watanabe,Norimichi　Chiyonobu,Keiichi Akahoshi,Toshiro Ogura,Kosuke Ogawa, Hiroaki Ono, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. What is predictive factor of postoperative diabetes mellitus in patients with distal pancreatectomy？. The 30th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2018.06.09 yokohama

  12. Toshiro Ogura, Tomotaka Kato, Masafumi Akasu, Jun Yoshino, Shuichi Watanabe, Norimichi Chiyonobu, Yuki Mizuno, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Yusuke Mitsunori,Daisuke Ban, Atsushi Kudo,Shinji Tanaka, Minoru Tanabe. The implication of lymph node metastasis on survival in cases with distal pancreatic cancer. The 30th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2018.06.09

  13. Shuichi Watanabe, Atsushi Kudo, Masafumi Akasu, Tomotaka Kato, Jun Yoshino, Norimichi Chiyonobu, Yuki Mizuno, Keiichi Akahoshi, Kosuke Ogawa, Toshiro Ogura, Yusuke Mitsunori, Hiroaki Ono, Daisuke Ban, Shinji Tanaka, Minoru Tanabe. The efficacy of liver SASI test for the the advanced functional PNET patients. The 30th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2018.06.09 Yokohama

  14. Jun Yoshino,Toshiro Ogura,Keiichi Akahoshi,Kosuke Ogawa, Yusuke Mitsunori,Hiroaki Ono, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Long-term outcomes and prognostic factors of patients with gallbladder cancer resection. The 30th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2018.06.08

  15. Akasu Masafumi, Kudo Atsushi, Kato Tomotaka, Yoshino Jun, Watanabe Shuichi, Chiyonobu Norimichi, Mizuno Yuki, Akahoshi Keichi, Ogura Toshiro, Ogawa Kosuke, Ono Hiroaki, Mitsunori Yusuke, Ban Daisuke, Tanaka Shinji, Tanabe Minoru. P-NETに対する分子標的薬の治療成績(The results of molecular targeted drugs to P-NET). 日本肝胆膵外科学会・学術集会プログラム・抄録集 2018.06.01

  16. Minoru Tanabe, Toshiro Ogura, Atsushi Kudo, Daisuke Ban, Shinji Tanaka. Surgery for Obese Patients with HCC. APASL2018 2018.05.12 Yokohama

  17. Tomotaka Kato,Atsushi Kudo, Hiroaki Ono, Masahumi Akasu, Jun Yoshino, Kosuke Ogawa, Toshiro Ogura , Yusuke Mitsunori, Daisuke Ban, Shinji Tanaka,Minoru Tanabe. A Surgical Case of Spontaneous and Asymptomatic Intrahepatic Hemorrhage with HCC. APASL2018 2018.05.12 Yokohama

  1. Fukamachi H, Nishikawaji T, Shimada S, Akiyama Y, Yuasa Y, Tsuchiya K, Tanaka S. . Identification of signal transduction pathway in PDX-derived diffuse-type gastric tumor-initiating cells.. 第76回日本癌学会総会 2017.09.30 横浜

  2. Akiyama Y, Nishikawaji T, Shimada S, Yuasa Y, Tanaka S.. Molecular mechanisms of SETDB2 histone methyltransferase overexpression in gastric cancer.. 第76回日本癌学会総会 2017.09.30 横浜

  3. Shimada S, Akiyama Y, Tanaka S.. Acquired resistance with epigenetic alterations under long-term anti-angiogenic therapy for hepatocellular carcinoma.. 第76回日本癌学会総会 2017.09.28 横浜

  4. 深町 博史, 西川路 武人, 島田 周, 秋山 好光, 湯浅 保仁, 土屋 輝一郎, 田中 真二. 低分化型胃がん幹細胞の増殖制御機構　患者由来がん幹細胞の初代培養系を用いた同定. 日本癌学会総会記事 2017.09.01

  5. 秋山 好光, 西川路 武人, 島田 周, 湯浅 保仁, 田中 真二. 胃がんにおけるヒストンメチル化酵素SETDB2高発現の分子機構. 日本癌学会総会記事 2017.09.01

  6. 深町 博史, 西川路 武人, 島田 周, 秋山 好光, 湯浅 保仁, 土屋 輝一郎, 田中 真二. 低分化型胃がん幹細胞の増殖制御機構　患者由来がん幹細胞の初代培養系を用いた同定. 日本癌学会総会記事 2017.09.01

  7. 島田 周, 秋山 好光, 田中 真二. 肝細胞がんにおける血管新生阻害療法に対する耐性獲得とエピジェネティクス変化. 日本癌学会総会記事 2017.09.01

  8. 光法雄介,赤星径一,巌康仁,小野宏晃,松村聡,伴大輔,落合高徳,工藤篤,田中真二,田邉稔. 胆肝細胞癌の局在はリンパ節郭清の適応や範囲の判断基準になりうるか. 第72回日本消化器外科学会総会 2017.07.21

  9. 渡辺　秀一. 再発形式による膵癌術後再発例の予後の差異の検討. 第72回日本消化器外科学会総会 2017.07.20

  10. Takehisa Yazawa、Hiroaki Ono¹、Yasuhito Iwao、Satoshi Matsumura、Yusuke Mitsunori、Daisuke Ban、Takanori Ochiai、Atsushi Kudo、Shinji Tanaka、Minoru Tanabe. Clinical significance of enhancing nodules in preoperative imaging studies of IPMN. 6th A-PHPBA 29th JSHBPS 2017.06.10 yokohama

  11. Takehiro Okabayashi、Daisuke Asano、Keiichi Akahoshi、Hiroaki Ono、Yusuke Mitsunori、Atsushi Kudo、Shinji Tanaka、Minoru Tanabe. The optimal management depending on the features of CT imaging of borderline resectable pancreatic cancer. 6th A-PHPBA & 29th JSHBPS 2017.06.09

  12. Ken-ichi Okada、Daisuke Ban、Keiichi Akahoshi、Yasuhito Iwao、Hiroaki Ono、Yusuke Mitsunori、Satoshi Matsumura、Atsushi Kudo、Shinji Tanaka、Minoru Tanabe. The optimal pancreatic stump closure method of a laparoscopic distalpancreatectomy: wrapping and fibrin capping technique. 6th A-PHPBA & 29th JSHBPS 2017.06.09

  13. Hiroki Ueda、Daisuke Ban、Atsushi Kudo、Takanori Ochiai、Shinji Tanaka、Minoru Tanabe . Refractory long-term cholangitis after pancreaticoduodenectomy: a retrospective study . 6th A-PHPBA & 29th JSHBPS 　 2017.06.09 yokohama

  14. Shuichi Watanabe、Daisuke Ban、Yasuhito Iwao、Keiichi Akahoshi、Akihiro Ono、Yusuke Mitsunori、Satoshi Matsumura、Takanori Ochiai、Atsushi Kudo、Shinji Tanaka、Minoru Tanabe. Study of the prognosis of recurrent pancreatic cancer: The significance of the solitary recurrence. 6th A-PHPBA &　29th　JSHBPS 2017.06.08 yokohama

  15. Atsushi Kudo、Daisuke Ban、Keiichi Akahoshi、Yusuke Mitsunori、Shinji Tanaka、Minoru Tanabe. Systemic therapy may decide surgical indication for patients with Unresectable of Metastatic Pancreatic Neuroendocrine Tumor. 6th A-PHPBA &　29th　JSHBPS 2017.06.08

  16. Atsushi Kudo、Daisuke Ban、Keiichi Akahoshi、Satoshi Matsumura、Yusuke MItsunori、Yasuhito Iwao、Shinji Tanaka、Minoru Tanabe. How to manage liver metastases of pancreatic NET?. 6th A-PHPBA & 29th JSHBPS 2017.06.08 yokohama

  17. Yusuke Mitsunori、Daisuke Ban、Hiroaki Ono、Keiichi Akahoshi、Yasuhito Iwao、Satoshi Matsumura、Takanori Ochiai、Atsushi Kudo、Shinji Tanaka、Minoru Tanabe. Can we predict postoperative diabetes mellitus in patient with distal pancreatectomy?. 6th A-PHPBA 29th JSHBPS 2017.06.08 yokohama

  18. Hiroaki Ono、Keiichi Akahoshi、Yasuhito Iwao、Satoshi Matsumura、Yuusuke Mitsunori、Daisuke Ban、Takanori Ochiai、Atsushi Kudo、Shinji Tanaka、Minoru Tanabe. Clinical evaluation of lymph node metastasis after surgery of IPMN. 6th A-PHPBA 29th JSHBPS 2017.06.08 yokohama

  19. Watanabe Shuichi, Ban Daisuke, Iwao Yasuhito, Akahoshi Keiichi, Ono Akihiro, Mitsunori Yusuke, Matsumura Satoshi, Ochiai Takanori, Kudo Atsushi, Tanaka Shinji, Tanabe Minoru. 再発性膵癌の予後の研究　孤立性再発の意義(Study of the prognosis of recurrent pancreatic cancer: The significance of the solitary recurrence). Journal of Hepato-Biliary-Pancreatic Sciences 2017.05.01

  20. Kudo Atsushi, Ban Daisuke, Akahoshi Keiichi, Mitsunori Yusuke, Tanaka Shinji, Tanabe Minoru. 切除不能または転移性の膵神経内分泌腫瘍を有する患者では全身療法により手術適応が決まる可能性がある(Systemic therapy may decide surgical indication for patients with Unresectable or Metastatic Pancreatic Neuroendocrine Tumor). Journal of Hepato-Biliary-Pancreatic Sciences 2017.05.01

  21. 田中 真二, 島田 周, 秋山 好光, 松村 聡, 光法 雄介, 藍原 有弘, 落合 高徳, 伴 大輔, 工藤 篤, 有井 滋樹, 田邉 稔. Precision medicine　bench to bedside　肝胆膵がんの分子サブタイプと治療抵抗性解析によるprecision medicineの展開. 日本外科学会定期学術集会抄録集 2017.04.01

  22. Ochiai T, Asano D, Yoshino J, Watanabe S, Ishikawa Y, Chiyonobu N, Mizuno Y, Sato T, Ueda H, Iwao Y, Ono H, Mitsunori Y, Matsumura S, Ban D, Kudo A, Tanaka S, Tanabe M. Surgical Strategy of Hepatic Resection with Inferior Vena Cava Resection for Liver Cancers. 12th Annual Academic Surgical Congress 2017.02.07 Las Vegas, USA

  1. Akiyama Y, Nishikawaji T, Shimada S, Deng D, Kim WH, Zhu WG, Yuasa Y, Tanaka S. Expression changes of the histone H3 lysine methyltransferase genes and their function in gastric cancer. 5th International Cancer Epigenetics Meeting 2016.10.22 Beijing, China

  2. Fukamachi H, Nishikawaji T, Shimada S, Akiyama Y, Yuasa Y, Tsuchiya K, Tanaka S. Characteristics of diffuse-type gastric cancer stem cells. 26th Seoul International Cancer Symposium 2016.06.17 Seoul, Korea

  3. Akiyama Y, Nishikawaji T, Shimada S, Yuasa Y, Tanaka S. Expression changes of the histone methyltransferase genes, SETDB2, in gastric cancers. 26th Seoul International Cancer Symposium 2016.06.17 Seoul, Korea

  4. Akiyama Y, Nishikawaji T, Shimada S, Sakamoto A, Deng D, Kim WH, Zhu WG, Yuasa Y Tanaka S. Reduced expression and its function of SET7/9, a histone methyltransferase gene, in gastric cancer. The 35th Sapporo International Cancer Symposium 2016 2016.05.24

  5. Shimada S, Akiyama Y, Fukamachi H, Yuasa Y, Tanaka S. Identification of selective inhibitors of diffuse-type gastric cancer cells by screening annotated compounds. AACR Annual Meeting 2016 2016.04.18 New Orleans, LA

  1. Tanaka S, Ogawa K, Matsumura S, Aihara A, Ban D, Ochiai T, Irie T, Kudo A, Arii S, Tanabe M. A preclinical study of EpCAM-targeted therapy for human hepatocellular carcinoma with stem cell features. 65th Annual Meeting of the American Association for the Study of Liver diseases 2014.11.10 Boston, USA

  2. Katsuta E, Kudo A, Ohata Y, Ueda H, Sato A, Oba A, Akahoshi K, Nakao K, Furuyama T,Ito H, Matsumura S, Aihara A, Ban D, Ochiai T, Irie T, Tanaka S, Tanabe M.. Morphology of pancreatic Neuroendocrine Tumor(P-NET). American Pancreatic Association 2014.11.08 Hawaii

  3. Akiyama Y, Koda Y, Nishikawaji T, Shimada S, Deng D, Kim WH, Zhu WG, Yuasa Y. Altered expression of the histone methyltransferase genes in gastric cancer.. 4th International Cancer Epigenetics Meeting 2014.10.19 Yangzhou, China

  4. Hiroki Ueda, Daisuke Ban, Yoshiteru Ohata, Taku Sato, Atsushi Ohba, Keiichi Akahoshi, Takaki Furuyama, Hiromitsu Ito, Keisuke Nakao, Eriko Katsuta, Satoshi Matsumura, Yusuke Mitsunori, Arihiro Aihara, Takanori Ochiai Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. The optimal dividing line of the jejunum for pancreatoduodenectomy. The Scientific Meeting of Japan-Hungary-Poland Surgical Society [Triangle Symposium 2014] 2014.10.18 Tokyo

  5. Tanaka S. “Novel molecular targets and therapeutic combinations in hepatocellular carcinoma; rationale and significance” (invited lecture). 4th International Kyoto Liver Cancer Symposium 2014.06.08 Kyoto

  6. Tanaka S, Ogawa K, Murakata A, Mogushi K, Matsumura S, Aihara A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Tanaka H, Arii S, Tanabe M. Preclinical studies of EpCAM-targeted therapy for human hepatocellular carcinoma with specific inhibition of stem cell features. 105th Annual Meeting of the American Association for Cancer Research 2014.04.06 San Diego, USA

  7. T. Ochiai, A. Shioya, H. Honma, Y. Saitoh, S. Matsumura, D. Ban, T. Irie, A. Kudo, N. Nakamura, T. Fujikawa, A. Itai, S. Tanaka, S. Arii, S. Yamaoka, M. Tanabe . Combination Treatment of IκB Kinase β Inhibitor IMD-0354 and Gemcitabine Suppresses Oncogenic Proliferation of Pancreatic Cancer Cells. 9th Annual Academic Surgical Congress 2014.02.04 San Diego, USA

  1. Shimada S. Targeting Epigenetic Alterations in a Mouse Model of E-cadherin/p53-deficient Diffuse-type Gastric Cancer.. The 4th JCA-AACR Special Joint Conference 2013.12

  1. Akiyama Y, Koda Y, Nishikawaji T, Shimada S, Zhu WG, Yuasa Y.. Loss of SET7, a histone H3K4 methyltransferase, in gastric cancer.. The 3rd International Cancer Epigenetics Meeting 2012.10 東京

  2. Akiyama Y, Nagasaki H, Yuasa Y.. Target gene analysis of GATA4 and GATA5 transcription factors in gastric cancer cells.. The 10th Japan-Korea Joint Symposium on Cancer and Ageing 2012.02 東京

  1. Shimada S, Mimata A, Mogushi K, Akiyama Y, Fukamachi H, Jonkers J, Tanaka H, Eishi Y, Yuasa Y. Mouse model of diffuse-type gastric cancer by conditional inactivation of E-cadherin and p53.. IGCC 2011 - 9th International Gastric Cancer Congress - NRF A3 Foresight Program 2011.04

  2. Akiyama Y, Nagasaki H, Yuasa Y. . Epigenetic alterations of GATA4 and GATA5 transcription factors in gastric cancers.. NRF A3 Foresight Program – IGCC2011 2011.04

  1. Akiyama Y, Nagasaki H, Yuasa Y. . Hypermethylation of GATA4 and GATA5 transcription factor genes and loss of their functions in gastric cancers.. The Second International Cancer Epigenetics Symposium 2010.10

  2. Akiyama Y, Nagasaki H, Yuasa Y. . Target gene analysis of GATA4/5 transcription factors in gastric cancers.. The 5th Asian Epigenomics Meeting & A3 Symposium 2010 2010.06 Jeju, 韓国

  3. Akiyama Y, Nagasaki H, Kawamoto A, Herman JG, Baylin SB, Yuasa Y.. Methylation of GATA4 and GATA5 transcription factor genes in gastric cancers.. 101st AACR Annual Meeting 2010.04 Washington DC, USA

  1. Akiyama Y, Hashimoto Y, Yuasa Y. . Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis.. The 9th Korea-Japan Symposium on Cancer and Ageing Research 2009.09 Damyang, 韓国

  2. 秋山好光、長崎弘美、湯浅保仁. . 胃がんにおける転写関連遺伝子GATA4/5のメチル化異常と機能解析.. 第3回日本エピジェネティクス研究会年会 2009.05 東京

  1. Akiyama Y, Wanajo A, Otsubo T, Nagasaki H, Yuasa Y.. Promoter hypermethylation of the calcium channel-related gene, CACNA2D3, is frequent and an independently poor prognostic factor in gastric carcinomas.. AACR Annual Meeting 2008 2008.04 San Diego, USA

  1. Akiyama Y, Yuasa Y. Hypermethylation of GATA4 and GATA5 transcription factor genes in gastric cancer. . The 12th Korea-Japan Cancer Research Workshop 2007.12

  2. Akiyama Y, Nagasaki H, Kawamoto A, Yuasa Y. GATA4 and GATA5 transcription factor genes were frequently silenced by methylation in gastric cancer. . The 8th Korea-Japan Joint Symposium on Cancer and Ageing Research 2007.08 岐阜

  1. 秋山好光、和南城愛良、佐々木茜、長崎弘美、湯浅保仁. 胃癌における電位依存性カルシウムチャンネル関連遺伝子のメチル化の解析.. 第65回日本癌学会総会 2006.09 横浜

  2. Akiyama Y, Wanajo A, Sasaki A, Yuasa Y. requent methylation of the calcium channel-related gene, CACNA2D3, in gastric cancers.. AACR, 97th Annual Meeting 2006.04 Washington DC, USA

  1. Akiyama Y, Wen X-Z & Yuasa Y. Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas. . The 7th Korea-Japan Joint Symposium on Cancer and Ageing Research 2005.11 Muju, 韓国

  1. Akiyama Y, Yuasa Y, Herman JG & Baylin SB. GATA–4 and GATA-5 transcription factor genes and potential downstream anti-tumor target genes are epigenetically silenced in colorectal and gastric cancer.. 6th Japan-Korea Workshop on Cancer and Aging Research 2004.02 徳島

  1. Hironari Yamashita, Hiroaki Ono, Kotaro Takizawa, Shuichi Watanabe, Kosuke Ogawa, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Atsushi Kudo, Yoshimitsu Akiyama, Shinji Tanaka, Minoru Tanabe. PCNA-I1 is identified as a novel therapeutic agent in pancreatic cancer. The 82nd Annual Meeting of the Japanese Cancer Association 2023.09.23 Yokohama

  2. Shu Shimada, Yoshimitsu Akiyama, Shinji Tanaka. RTP4 silencing provokes tumor-intrinsic resistance to immunecheckpoint blockade in colorectal cancer. The 82nd Annual Meeting of the Japanese Cancer Association 2023.09.22 Yokohama

  1. Shu Shimada, Yoshimitsu Akiyama, Shinji Tanaka. Intrinsic activation of β-catenin signaling by CRISPR/Cas9- mediated exon skipping contributes to immune evasion in HCC. The 81st Annual Meeting of the Japanese Cancer Association. 2022.09.30 Yokohama

  1. Shinji Tanaka. JCA-Mauverney Award Session Invited Lecture; Surgical oncology to develop novel targeted and immunotherapies for hepato-biliary-pancreatic cancer. 80th Annual Meeting of Japanese Cancer Association 2021.10.02 Yokohama

  2. Shu Shimada, Shinji Tanaka.. Establishment of molecular-immunological subtypes and development of specific models for therapeutic application in hepatocellular carcinoma.. The 80th Annual Meeting of the Japanese Cancer Association. 2021.09.30 Yokohama

  1. Shu Shimada, Yoshimitsu Akiyama, Shigeki Arii, Minoru Tanabe, Shinji Tanaka. Comprehensive molecular and immunological classification of hepatocellular carcinoma. The 56th Annual Meeting of Liver Cancer Study Group of Japan 2020.12.22 Online

  2. Akiyama Y, Shimada S, Tanabe M, Tanaka S. Loss of ARID1A increases a stemness gene ALDH1A1 expression through histone acetylation change in cholangiocarcinoma. The 79th Annual Meeting of the Japanese Cancer Association 2020.10.01 Yokohama, Online

  3. Shimada S, Akiyama Y, Tanabe M, Tanaka S. Loss of KDM6A characterizes a poor prognostic subtype of pancreatic cancer and potentiates HDAC inhibitor lethali . The 79th Annual Meeting of the Japanese Cancer Association 2020.10.01 Yokohama, Online

  4. Shimada S, Akiyama Y, Tanaka S. Loss of KDM6A characterizes a poor prognostic subtype of pancreatic cancer and potentiates HDAC inhibitor lethality . The 23rd Frontier Scientists Workshop, Post A3-2020 Symposium on Epigenetic Signature of Carcinogenesis 2020.09.19 Seoul, Korea, Online

  5. Fukiko Kawai-Kitahata, Yasuhiro Asahina , Sei Kakinuma, Miyako Murakawa, Sayuri Nitta, Masato Miyoshi, Ayako Sato, Jun Tsuchiya, Taro Shimizu, Eiko Takeichi, Mina Nakagawa, Yasuhiro Itsui, Seishin Azuma, Shinji Tanaka , Minoru Tanabe, Shinya Maekawa, Nobuyuki Enomoto and Mamoru Watanabe.. Comprehensive analysis of cancer-related genes and aav/hepatitis b virus integration into genome on development of hepatocellular carcinoma in patients with prior hepatitis b virus infection.. EASL The Digital International Liver Congress 2020 2020.08.28 Online

  1. Shinji Tanaka, Shuichi Watanabe, Minoru Tanabe.. Novel genetic and immunological classification of hepatocellular carcinoma for the subtype-specific precision immunotherapy. JAPAN DIGESTIVE DISEASE WEEK 2019 2019.11.22 Kobe

  2. Yoshimitsu Akiyama, Shu Shimada, Shinji Tanaka. Overexpression of histone arginine methyltransferase PRMT6 contributes to prognosis and malignancy of gastric cancer. The 78th Annual Meeting of the Japanese Cancer Association 2019.09.27 Kyoto

  3. Shu Shimada, Yoshimitsu Akiyama, Shinji Tanaka. Comprehensive molecular and immunological characterization of hepatocellular carcinoma. The78th Annual Meeting of the Japanese Cancer Association 2019.09.26 kyoto

  4. Asymmetric dimethylation at histone H3 arginine 2 by PRMT6 in gastric cancer progression. 2019.05.28

  1. Yoshimitsu Akiyama, Shu Shimada, Minoru Tanabe, Shinji Tanaka. DAXX acts as a tumor suppressor through histone H3.3/H3K9me3 pathway in pancreatic neuroendocrine tumors. The 77th Annual Meeting of the Japanese Cancer Association 2018.09.29 Osaka

  2. Shinji Tanaka. Molecular target therapy under precision medicine. 77th Annual Meeting of Japanese Cancer Association 2018.09.28 Osaka

  3. Shu Shimada, Norimichi Chiyonobu, Yoshimitsu Akiyama, Shinji Tanaka. FABP4 overexpression in intratumoral hepatic stellate cells within hepatocellular carcinoma with metabolic risk factors.. The 77th Annual Meeting of the Japanese Cancer Association 2018.09.28 Osaka

  4. Yuki Mizuno, Shu Shimada, Yoshimitsu Akiyama, Shuichi Watanabe,Tomomi Aida, Kosuke Ogawa,Hiroaki Ono, Yusuke Mitsunori,Daisuke Ban, Atsushi Kudo, Shoji Yamaoka, Shinji Tanaka, Minoru Tanabe. DEPDC5 deficiency contributes to resistance to leucine starvation via p62 accumulation in hepatocellular carcinoma. 2018.09.28

  5. Shinji Tanaka, Atsushi Oba, Shu Shimada, Yoshimitsu Akiyama, Kosuke Ogawa, Hiroaki Ono, Yusuke Mitsunori, Daisuke Ban, Atsushi Kudo, Shigeki Arii, Minoru Tanabe. Precision immunotherapy for hypermutator and immunogenic subtypes of hepatocellular carcinoma. 73rd General Meeting of the Japanese Society of Gastroenterological Surgery 2018.07.12 Kagoshima

  6. Shinji Tanaka. Precision medicine for HCC and pancreatic cancer . The 7th International Forum of The Japanese Society of Gastroenterology Jointly with the 12th International Symposium on ALPD and Cirrhosis 2018.04.19 Tokyo

  1. Shu Shimada, Yoshiteru Ohata, Yoshimitsu Akiyama, Shinji Tanaka. Acquired resistance with epigenetic alterations under long-term anti-angiogenic therapy for hepatocellular carcinoma. The 76th Annual Meeting of the Japanese Cancer Association 2017.09.28 Yokohama

  2. Tanaka S, Oba A, Ogawa Y, Ono H, Mitunori Y, Ban D, Kudo A, Arii S, Tanabe M. . Personalized medicine to target the cancer stemness of hepato-biliary-pancreatic malignancies (Symposium).. The 72rd General Meeting of the Japanese Society of Gastroenterological Surgery 2017.07.22 Kanazawa

  3. Tanaka S, Shimada S, Akiyama Y, Muramatu S, Mitumori Y, Aihara A, Ocjoai T, Ban D, Kudo A, Arii S, Tanabe M.. Significance of molecular subtypes and therapeutic resistance mechanisms in hepato-biliary-pancreatic malignancies for precision cancer medicine . The 117th Annual Congress of Japan Surgical Society 2017.04.27 Yokohama

  1. Shimada S, Akiyama Y, Fukamachi H, Yuasa Y, Tanaka S. Identification of selective inhibitors of diffuse-type gastric cancer cells by screening of annotated compounds. The 75th Annual Meeting of the Japanese Cancer Association 2016.10.07 Yokohama

  2. Akiyama Y, Nishikawaji T, Shimada S, Sakamoto A, Yuasa Y, Tanaka S. Reduced expression of SET7/9, a histone mono-methyltransferase, is associated with gastric cancer progression. The 75th Annual Meeting of the Japanese Cancer Association 2016.10.07 Yokohama

  3. Nishikawaji T, Akiyama Y, Shimada S, Yuasa Y, Tanaka S. SETDB2 contributes to gastric cancer progression by deregulating the expression of tumor suppressor genes. The 75th Annual Meeting of the Japanese Cancer Association 2016.10.06 Yokohama

  4. Fukamachi H, Nishikawaji T, Shimada S, Akiyama Y, Yuasa Y, Tanaka S. Identification of MTDs that suppress the growth of PDX-derived duffuse-type gastric tumor-initiating cells. The 75th Annual Meeting of the Japanese Cancer Association 2016.10.06 Yokohama

  5. Tanaka S, Shimada S, Akiyama Y. Epigenetic target of stemness for metastasis and therapeutic resistance in patients with pancreatic and liver cancers. The 75th Annual Meeting of the Japanese Cancer Association 2016.10.06 Yokohama

  6. Tanaka S, Ito H, Furuyama T, Aihara A, Matsumura S, Mitsunori Y, Ban D, Ochiai T, Kudo A, Tanabe M. Personalized medicine to target the cancer stemness of hepato-biliary-pancreatic malignancies (Symposium).. The 72th Annual Meeting of the Japanese Society of Gastroenterological Surgery 2016.07.15 Tokushima

  7. Akiyama Y, Nishikawaji T, Shimada S, Sakamoto A, Deng D, Kim WH, Zhu WG, Yuasa Y, Tanaka S. Reduced expression and its function of SET7/9, a histone methyltransferase gene, in gastric cancer. The 35th Sapporo International Cancer Symposium 2016.06.24 Sapporo

  1. Tanaka S. Surgical oncology for identification of novel molecular targets in refractory cancers (symposium). The 74th Annual Meeting of the Japanese Cancer Association 2015.10.09 Nagoya

  2. Sakamoto A, Shimada S, Akiyama Y, Yuasa Y, Tanaka S. Epigenetic regulation of Twist1 in diffuse-type gastric cancer cell lines of an E-cadherin/p53-deficient mouse model. The 74th Annual Meeting of the Japanese Cancer Association 2015.10.09 Nagoya

  3. Nishikawaji T, Akiyama Y, Shimada S, Yuasa Y, Tanaka S. Oncogenic roles of SETDB2, a histone methyltransferase, in human gastric carcinogenesis. The 74th Annual Meeting of the Japanese Cancer Association 2015.10.09 Nagoya

  4. Akiyama Y, Koda Y, Nishikawaji T, Shimada S, Sakamoto A, Yuasa Y, Tanaka S. Transcriptional regulatory mechanism of SET7/9 in gastric cancer. The 74th Annual Meeting of the Japanese Cancer Association 2015.10.09 Nagoya

  5. Tanaka S, Aihara A, Tanabe M. Molecular pathogenesis and targeted therapy for major vascular invasiveness of hepatocellular carcinoma (symposium). The 13th General Meeting of the Japanese Society of Gastroenterological Surgery 2015.10.08 Tokyo

  1. Tanaka S, Adikrisna R, Mogushi K, Matsunaga H, Matsumura S, Aihara A, Ochiai T, Tanaka H, Yamaoka S, Arii S. Visualized cancer stem cells for analysis of heterogenic expansion and microenvironments with tumor-host interaction (symposium). The 73th Annual Meeting of the Japanese Cancer Association 2014.09.25 Yokohama

  2. Tanaka S, Aihara A, Matsumura S, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Arii S, Tanabe M. Molecular targeted therapy for major vascular invasiveness of hepatocellular carcinoma (symposium). The 26th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2014.06.12 Wakayama

  3. Aurora /VEGF-R2 dual kinase inhibitor as a novel treatment for hepatocellular carcinoma. 2014.04.04

To the head of this page.▲